Metabolic Activation of a Pyrazinone-Containing Thrombin Inhibitor. Evidence for Novel Biotransformation Involving Pyrazinone Ring Oxidation, Rearrangement, and Covalent Binding to Proteins
- 24 January 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 16 (2) , 198-207
- https://doi.org/10.1021/tx025635l
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Hepatotoxicity of Commonly Used Drugs: Nonsteroidal Anti-Inflammatory Drugs, Antihypertensives, Antidiabetic Agents, Anticonvulsants, Lipid-Lowering Agents, Psychotropic DrugsSeminars in Liver Disease, 2002
- Mass spectrometry in the analysis of glutathione conjugatesJournal of Mass Spectrometry, 1993
- Covalent and Noncovalent Interactions in Acute Lethal Cell Injury Caused by ChemicalsAnnual Review of Pharmacology and Toxicology, 1990